#AANAM – Findings Due in Japan Study of Repurposed ALS Therapy

#AANAM – Findings Due in Japan Study of Repurposed ALS Therapy

292580

#AANAM – Findings Due in Japan Study of Repurposed ALS Therapy

Editor’s note: The ALS News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the latest stories from the conference. Treatment is complete in 20 patients enrolled in the randomized ROPALS clinical trial assessing the safety, tolerability and early efficacy of ropinirole hydrochloride as a repurposed oral therapy — identified through stem cell work — for amyotrophic lateral sclerosis (ALS). Full results from this part of the Phase 1/2a…

You must be logged in to read/download the full post.